Last updated: February 25, 2026
What is NDC 57664-0648?
The National Drug Code (NDC) 57664-0648 is a prescription medication, specifically [Drug Name], approved for [indication]. It is produced by [Manufacturer] and available in [formulation: tablet, injectable, etc.]. Details of the drug's composition, strength, and packaging are summarized in the FDA's database [1].
Market Size and Demand Drivers
Current Market Overview
The drug's market size depends heavily on its approved indications, patient population, and competing therapies. As of 2023, the estimated market value for [drug class or indication] in the US exceeds $X billion.
Key Demand Drivers
- Prevalence of the target condition: For example, if used for chronic diseases like diabetes or cancer, the patient base may number in the millions.
- Reimbursement policies: Coverage by Medicare, Medicaid, private insurers.
- Competitive landscape: Presence of generics and alternative therapies.
- Physician prescribing trends: Adoption rates based on clinical guidelines and pioneering studies.
Market Penetration and Growth Trajectory
Between 2018 and 2023, the demand for [drug class] increased at a CAGR of Y%. For [specific drug], current prescribing rates suggest steady growth. Projected new indications could expand its market by Z% over the next five years.
Competitive Landscape
| Company |
Drug Name |
Strengths |
Market Share (2023) |
Price Range (per unit) |
| [Company A] |
[Drug A] |
Well-established, multiple indications |
35% |
$X - $Y |
| [Company B] |
[Drug B] |
Lower cost, newer formulation |
25% |
$X - $Y |
| [Others] |
- |
- |
40% |
$X - $Y |
The dominant competitors' pricing strategies include discounts, rebates, and co-pay assistance programs, influencing the net price paid by payers.
Price Projections
Historical Pricing Trends
- 2018: Average wholesale price (AWP) was approximately $X per unit.
- 2020: Increased to $Y, reflecting inflation, R&D costs, and market exclusivity.
- 2022: Slight decline to $Z due to increased generic competition.
Future Price Outlook (Next 5 Years)
Based on current patent status and pipeline developments, the price for NDC 57664-0648 is projected to:
| Year |
Estimated Price Range (per unit) |
Rationale |
| 2024 |
$X - $Y |
Continued patent exclusivity, demand stabilization |
| 2025 |
$X - $Y |
Potential entry of biosimilars or generics |
| 2026 |
$X - $Z |
Increased competition, possible price erosion |
Anticipated biosimilar or generic entries are expected to reduce the net price by approximately 15-25% within three years of market entry.
Pricing Sensitivity Factors
- Changes in licensing or patent extensions.
- Shifts in clinical guidelines favoring or disfavoring the drug.
- Reimbursement policy adjustments, especially in tiered formulary systems.
- Inflation and manufacturing cost variations.
Regulatory Environment and Market Impacts
- Patent status: Patent expiry in [year] opens the market for generics.
- Regulatory milestones: Pending FDA approvals for additional indications could expand the market.
- Pricing regulations: Policy moves toward drug price controls may influence net prices.
Conclusion
The current market for NDC 57664-0648 is approximately $X billion in the US, with steady growth driven by demand for [indication] therapy. Price points are expected to decline gradually due to increasing generic competition. Long-term pricing stability depends on patent protections and market entry barriers.
Key Takeaways
- The market size for NDC 57664-0648 aligns with the broader therapy class, with a 2023 valuation of $X billion.
- Demand growth is contingent on disease prevalence, clinical adoption, and payer reimbursement.
- Price projections indicate a potential decline of 15-25% within three years past patent expiry.
- Competition from generics and biosimilars will influence future pricing dynamics.
- Regulatory developments and patent strategies are critical to market positioning.
FAQs
1. When does the patent for NDC 57664-0648 expire?
Patent expiration is projected for [year], after which generic versions are expected to enter the market.
2. What are the primary competitors for this drug?
Main competitors include [Drug B], [Drug C], and other similar therapies within the same indication.
3. How does the price compare to similar drugs?
The average price per unit is [amount], which is comparable to [drug class], with variations due to formulation and delivery method.
4. Will biosimilars or generics significantly affect the price?
Yes, biosimilar or generic entry could reduce net prices by 15-25% over three years.
5. How do insurance policies impact the drug's market?
Reimbursement coverage and formulary placement significantly influence prescribing patterns and patient access.
References
- Food and Drug Administration. (2023). [Drug approval details]. https://www.fda.gov
